Radiomics study for predicting the expression of PD-L1 in non -small cell lung cancer based on CT images and clinicopathologic features

被引:4
|
作者
Sun, Zongqiong [1 ,2 ]
Hu, Shudong [2 ]
Ge, Yuxi [2 ]
Wang, Jun [3 ]
Duan, Shaofeng [4 ]
Song, Jiayang [4 ]
Hu, Chunhong [1 ]
Li, Yonggang [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Dept Radiol, Suzhou 215006, Jiangsu, Peoples R China
[2] Jiangnan Univ, Affiliated Hosp, Dept Radiol, Wuxi, Jiangsu, Peoples R China
[3] Shanghai Univ, Shanghai Inst Adv Commun & Data Sci, Sch Commun & Informat Engn, Shanghai, Peoples R China
[4] Gen Elect GE Healthcare China, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
IMMUNOTHERAPY; BIOMARKERS; CHALLENGES; STATISTICS; RISK;
D O I
暂无
中图分类号
TH7 [仪器、仪表];
学科分类号
0804 ; 080401 ; 081102 ;
摘要
引用
收藏
页码:449 / 459
页数:11
相关论文
共 50 条
  • [31] PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer
    Wu, Xiaodong
    Huang, Yan
    Zhao, Qingping
    Wang, Lei
    Song, Xiao
    Li, Yi
    Jiang, Lei
    EJNMMI RESEARCH, 2020, 10 (01)
  • [32] Research progression of PD-1/PD-L1 in non-small cell lung cancer
    Xing Liu
    Xiaodong Xie
    Oncology and Translational Medicine, 2017, 3 (03) : 111 - 115
  • [33] Correlation between immunotherapy biomarker PD-L1 expression and genetic alteration in patients with non-small cell lung cancer
    Chen, Hefeng
    Ge, Mengxi
    Zhang, Fuchuang
    Xing, Yishi
    Yu, Shicheng
    Chen, Chunzhu
    Zhang, Hougang
    Wang, Xiaoyong
    Gao, Xing
    Chen, Fangtao
    Chen, Peilin
    Zhang, Dadong
    Zhan, Qiong
    Zhu, Youcai
    GENOMICS, 2023, 115 (04)
  • [34] Advanced non-small cell lung cancer: the role of PD-L1 inhibitors
    Heigener, David F.
    Reck, Martin
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1468 - S1473
  • [35] Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancer
    Aviles-Salas, Alejandro
    Flores-Estrada, Diana
    Lara-Mejia, Luis
    Catalan, Rodrigo
    Cruz-Rico, Graciela
    Orozco-Morales, Mario
    Heredia, David
    Bolano-Guerra, Laura
    Soberanis-Pina, Pamela Denisse
    Varela-Santoyo, Edgar
    Cardona, Andres F.
    Arrieta, Oscar
    THORACIC CANCER, 2022, 13 (23) : 3362 - 3373
  • [36] PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC)
    Jiang, Liyan
    Su, Xinying
    Zhang, Tianwei
    Yin, Xiaolu
    Zhang, Meizhuo
    Fu, Haihua
    Han, Hulin
    Sun, Yun
    Dong, Lili
    Qian, Jialin
    Xu, Yanhua
    Fu, Xuan
    Gavine, Paul R.
    Zhou, Yanbin
    Tian, Kun
    Huang, Jiaqi
    Shen, Dong
    Jiang, Haiyi
    Yao, Yihong
    Han, Baohui
    Gu, Yi
    ONCOTARGET, 2017, 8 (16) : 26845 - 26857
  • [37] Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer
    Scheel, Andreas H.
    Baenfer, Gudrun
    Baretton, Gustavo
    Dietel, Manfred
    Diezko, Rolf
    Henkel, Thomas
    Heukamp, Lukas C.
    Jasani, Bharat
    Joehrens, Korinna
    Kirchner, Thomas
    Lasitschka, Felix
    Petersen, Iver
    Reu, Simone
    Schildhaus, Hans-Ulrich
    Schirmacher, Peter
    Schwamborn, Kristina
    Sommer, Ulrich
    Stoss, Oliver
    Tiemann, Markus
    Warth, Arne
    Weichert, Wilko
    Wolf, Juergen
    Buettner, Reinhard
    Rueschoff, Josef
    HISTOPATHOLOGY, 2018, 72 (03) : 449 - 459
  • [38] Companion and Complementary Diagnostics-Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Hersom, Maria
    Jorgensen, Jan T.
    THERAPEUTIC DRUG MONITORING, 2018, 40 (01) : 9 - 16
  • [39] Biomarkers of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Beyond PD-L1
    Cabezon-Gutierrez, Luis
    Custodio-Cabello, Sara
    Palka-Kotlowska, Magda
    Alonso-Viteri, Soledad
    Khosravi-Shahi, Parham
    CLINICAL LUNG CANCER, 2021, 22 (05) : 381 - 389
  • [40] PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)
    Krenbek, Dagmar
    Weidinger, Barbara
    Jarius, Christa
    Holzer, Sophia
    Fabican, Hannah
    Mohn-Staudner, Andrea
    Hochmair, Maximilian
    Chott, Andreas
    Setinekl, Ulrike
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S430 - S430